SenoVax™ Platform

About Immorta Bio

Immorta Bio is an early-stage, private biotech focused on pioneering therapies to reverse aging. The company is advancing two core technology platforms: SenoVax™, an autologous approach to eliminate senescent cells, and StemCell Revivify™, designed to rebuild damaged organs and tissues with stem cells. While still in pre-clinical development, the company has reported promising mouse model data showing lifespan extension. It is led by a team of seasoned biotech entrepreneurs and pharmaceutical industry veterans.

Therapeutic Areas